Sian Bigora

Insider Reports History

Entity
Individual
Location
7380 Coca Cola Drive, Suite 106, Hanover, MD
Signature
/s/ Sian Bigora by Michael B. Kirwan, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sian Bigora:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Processa Pharmaceuticals, Inc. Chief Development Officer Restricted Stock Units 28K $47.8K $1.71 Jun 28, 2024 Direct
Processa Pharmaceuticals, Inc. Chief Development Officer Common Stock 21.9K $37.4K $1.71 Jul 10, 2024 Direct
Processa Pharmaceuticals, Inc. Chief Development Officer Common Stock 6.67K $11.4K $1.71 Apr 5, 2024 By CorLyst, LLC

Insider Reports Filed by Sian Bigora

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PCSA Processa Pharmaceuticals, Inc. Apr 5, 2024 8 -$1.41K 4 Aug 2, 2024 Chief Development Officer
PCSA Processa Pharmaceuticals, Inc. Jan 1, 2024 3 -$1.03K 4 Apr 12, 2024 Chief Development Officer
PCSA Processa Pharmaceuticals, Inc. Dec 31, 2022 3 $0 4 Jan 4, 2023 Chief Development Officer
PCSA Processa Pharmaceuticals, Inc. Sep 30, 2022 1 $0 4 Oct 3, 2022 Chief Development Officer
PCSA Processa Pharmaceuticals, Inc. Aug 5, 2022 1 $0 4 Aug 9, 2022 Chief Development Officer
PCSA Processa Pharmaceuticals, Inc. Jun 30, 2022 1 $0 4 Jul 5, 2022 Chief Development Officer
PCSA Processa Pharmaceuticals, Inc. Apr 1, 2022 1 $0 4 Apr 11, 2022 Chief Development Officer
PCSA Processa Pharmaceuticals, Inc. Dec 31, 2021 1 $0 4/A Jan 6, 2022 Chief Development Officer
PCSA Processa Pharmaceuticals, Inc. Nov 1, 2021 2 $0 4 Apr 4, 2022 Chief Development Officer
PCSA Processa Pharmaceuticals, Inc. Sep 30, 2021 1 $0 4/A Jan 6, 2022 Chief Development Officer
PCSA Processa Pharmaceuticals, Inc. Aug 5, 2021 1 $0 4 Aug 9, 2021 Chief Development Officer
PCSA Processa Pharmaceuticals, Inc. Jul 8, 2021 3 $0 4 Jul 9, 2021 Chief Development Officer
PCSA Processa Pharmaceuticals, Inc. Jun 8, 2021 1 $0 4 Jun 10, 2021 Chief Development Officer